User profiles for José Camilla Sammartino
 | JOSE' CAMILLA SAMMARTINOResearcher, Università degli Studi di Pavia Dipartimento di Scienze Clinico-Chirurgiche … Verified email at iusspavia.it Cited by 1383 |
[HTML][HTML] Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in∼ 40% of patients
…, D Lilleri, C Fornara, JC Sammartino… - Journal of Experimental …, 2023 - rupress.org
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for …
[HTML][HTML] Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
Nontuberculous mycobacteria (NTM) have recently emerged as important pathogens among
cystic fibrosis (CF) patients worldwide. Mycobacterium abscessus is becoming the most …
cystic fibrosis (CF) patients worldwide. Mycobacterium abscessus is becoming the most …
[HTML][HTML] Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
Neutralizing antibodies that target the receptor-binding domain (RBD) of the SARS-CoV-2
spike protein are among the most promising approaches against COVID-19 1 , 2 . A bispecific …
spike protein are among the most promising approaches against COVID-19 1 , 2 . A bispecific …
[HTML][HTML] In vitro study of bedaquiline resistance in Mycobacterium tuberculosis multi-drug resistant clinical isolates
G Degiacomi, JC Sammartino, V Sinigiani… - Frontiers in …, 2020 - frontiersin.org
Tuberculosis (TB) is one of the major causes of death related to antimicrobial resistance
worldwide because of the spread of Mycobacterium tuberculosis multi- and extensively drug …
worldwide because of the spread of Mycobacterium tuberculosis multi- and extensively drug …
[HTML][HTML] Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …
the urgent need to study more efficient vaccination strategies. Here we observed that an …
[HTML][HTML] Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
…, MA Ynga-Durand, H Maass, JC Sammartino… - BMC medicine, 2022 - Springer
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
November 2021, the Omicron variant was discovered and immediately classified as a variant of …
[HTML][HTML] SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
…, A Piralla, F Giardina, JC Sammartino… - Nature …, 2021 - nature.com
Vaccine breakthrough SARS-CoV-2 infection has been monitored in 3720 healthcare workers
receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects, with a …
receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects, with a …
[PDF][PDF] Immunity to SARS-CoV-2 up to 15 months after infection
…, J Andréll, E Percivalle, JC Sammartino… - IScience, 2022 - cell.com
Information concerning the longevity of immunity to SARS-CoV-2 following natural infection
may have considerable implications for durability of immunity induced by vaccines. Here, we …
may have considerable implications for durability of immunity induced by vaccines. Here, we …
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
The emergence of Omicron lineages and descendent subvariants continues to present a
severe threat to the effectiveness of vaccines and therapeutic antibodies. We have previously …
severe threat to the effectiveness of vaccines and therapeutic antibodies. We have previously …
[HTML][HTML] Multitargeting compounds: a promising strategy to overcome multi-drug resistant tuberculosis
Tuberculosis is still an urgent global health problem, mainly due to the spread of multi-drug
resistant M. tuberculosis strains, which lead to the need of new more efficient drugs. A …
resistant M. tuberculosis strains, which lead to the need of new more efficient drugs. A …